News Industry News Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa(R) June 11, 2014
News Industry News US FDA approves EPANOVA for the treatment of adults with severe hypertriglyceridaemia May 06, 2014